Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter August 17, 2020

Let’s Make a (Smart) Deal: Biodiplomacy in the Age of Trump

Noah Blaine Hearn


North Korea poses significant risks to national security as it continues to develop weapons of mass destruction (WMDs). On February 28, 2019, United States President Donald Trump announced that he would be departing his second summit with Kim Jong Un without having reached a deal regarding the denuclearization of North Korea. This anticlimactic outcome followed weeks of media buildup surrounding the two leaders’ meeting in Hanoi, Vietnam; however, negotiators from both countries have pledged to continue their efforts at crafting a deal. As they continue this endeavor, those with a seat at the negotiating table must recognize that the most prudent path forward for the United States is to ensure that any such disarmament deal also address North Korea’s capacity to develop of biological weapons (BWs) in addition to nuclear and chemical capabilities as part of a comprehensive strategy.

Corresponding author: Noah Blaine Hearn, Texas Tech University School of Law, 3311 18th st, Lubbock, Texas, 79409-0004, USA

Published Online: 2020-08-17

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow